General MedicationsORALStandard
DOXYCYCLINE
DOXYCYCLINE
Standard Dose
EQ 25MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview DOXYCYCLINE is listed in Drugs@FDA under application 201678 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DOXYCYCLINE Form and strength FOR SUSPENSION;ORAL - EQ 25MG BASE/5ML Sponsor LUPIN LTD Submission history Latest submission status date: 2025-03-31 00:00:00.
Structured Monograph
Clinical summary
Approval overview DOXYCYCLINE is listed in Drugs@FDA under application 201678 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DOXYCYCLINE Form and strength FOR SUSPENSION;ORAL - EQ 25MG BASE/5ML Sponsor LUPIN LTD Submission history Latest submission status date: 2025-03-31 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.